Dronedarone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB04855 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 36 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | stroke disorder | KG + DL |
| 2 | obsolete susceptibility to ischemic stroke | KG + DL |
| 3 | ABri amyloidosis | KG + DL |
| 4 | cerebrovascular disorder | KG + DL |
| 5 | brain stem infarction | KG + DL |
| 6 | sick sinus syndrome 2, autosomal dominant | KG + DL |
| 7 | duodenal obstruction | KG + DL |
| 8 | cerebral artery occlusion | KG + DL |
| 9 | sarcoglycanopathy | KG + DL |
| 10 | Wildervanck syndrome | KG + DL |
| 11 | manic bipolar affective disorder | KG + DL |
| 12 | duodenal ulcer (disease) | KG + DL |
| 13 | duodenogastric reflux | KG + DL |
| 14 | spinal cord ischemia | KG + DL |
| 15 | macrocephaly, dysmorphic facies, and psychomotor retardation | KG + DL |
| 16 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 17 | transient ischemic attack (disease) | KG + DL |
| 18 | Prinzmetal angina | KG + DL |
| 19 | MRI defined brain infarct | KG + DL |
| 20 | cerebral infarction | KG + DL |
| 21 | intracerebral hemorrhage | KG + DL |
| 22 | homozygous familial hypercholesterolemia | KG + DL |
| 23 | cerebral arterial disease | KG + DL |
| 24 | spheroid body myopathy | KG + DL |
| 25 | periodic paralysis with transient compartment-like syndrome | KG + DL |
| 26 | ABeta amyloidosis | KG + DL |
| 27 | brain ischemia | KG + DL |
| 28 | lateral sinus thrombosis | KG + DL |
| 29 | cavernous sinus thrombosis | KG + DL |
| 30 | cholesterol embolism | KG + DL |
| 31 | catecholaminergic polymorphic ventricular tachycardia | KG + DL |
| 32 | arrhythmogenic right ventricular cardiomyopathy | KG + DL |
| 33 | brachydactyly-syndactyly syndrome | KG + DL |
| 34 | sagittal sinus thrombosis | KG + DL |
| 35 | ventricular tachycardia | KG + DL |
| 36 | rheumatoid arthritis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.